Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,512 public trials 681 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246

NCT03268382

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • Medische oncologie, Universitair Ziekenhuis Gent Ghent, Belgium
  • Leuven University Hospitals Leuven, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
  • Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Spain
View Trial Details
Completed

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

NCT02489903

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • Stanford University Palo Alto, California, United States
  • VA Connecticut Cancer Center West Haven, Connecticut, United States
  • Memorial Hospital of South Bend South Bend, Indiana, United States
  • Baptist Health Lexington, Kentucky, United States
View Trial Details
Completed

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

NCT02098343

Conditions
Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 55 locations
View Trial Details

Related conditions